CLEARASIL ULTRA ACNE CLEARING SCRUB- salicylic acid solution 
RB Health (US) LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clearasil
Ultra ®

Drug Facts

Active Ingredient

Salicylic Acid 2%

Purpose

Acne medication

Use

for the treatment of acne

Warnings

For external use only

When using this product

  • avoid contact with the eyes. If product gets into the eyes rinse thoroughly with water.
  • with other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one acne medication should be used unless directed by a doctor.
  • limit use to the face and neck.

Stop use and ask doctor ifskin or eye irritation develops

Keep out of reach of children.In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

Other information

Inactive ingredients

Water, Polyethylene, PPG-15 Stearyl Ether, Glycerin, Stearyl Alcohol, Cetyl Betaine, Distearyldimonium Chloride, Sodium Lauryl Sulfate, Cetyl Alcohol, Alcohol, Steareth-21, Sodium Chloride, Behenyl Alcohol, Synthetic Wax, Steareth-2, Fragrance, Xanthan Gum, Lavandula Stoechas Extract, Helichrysum Italicum Extract, Cistus Monspeliensis Extract, Lauryl Alcohol, Mica, Disodium EDTA, PEG-40 Hydrogenated Castor Oil, BHT, Magnesium Nitrate, Phenoxyethanol, Methylparaben, Methylchloroisothiazolinone, Magnesium Chloride, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben, Methylisothiazolinone, Ferric Ferrocyanide, Titanium Dioxide, Blue1.

For best before date see tube seal.

www.clearasil.com

Questions? Comments?

Call 1-866-25-CLEAR
(1-866-252-5327)*

Distributed by: Reckitt Benckiser Inc.
Parsippany, NJ 07054-0224
Made in USA © RBI 2009

0223412

PRINCIPAL DISPLAY PANEL - 150 mL Label

Dermatologist
Tested

Clearasil
Ultra ®

NEW
FORMULA

Acne Clearing
Scrub

100%

Fights 100% of acne

2% SALICYLIC ACID ACNE MEDICATION
5 FL. OZ. (150 mL)

Principal Display Panel
CLEARASIL ULTRA  ACNE CLEARING SCRUB
salicylic acid solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-318
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
HIGH DENSITY POLYETHYLENE (UNII: UG00KM4WR7)  
PPG-15 STEARYL ETHER (UNII: 1II18XLS1L)  
GLYCERIN (UNII: PDC6A3C0OX)  
STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
CETYL BETAINE (UNII: E945X08YA9)  
DISTEARYLDIMONIUM CHLORIDE (UNII: OM9573ZX3X)  
SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
ALCOHOL (UNII: 3K9958V90M)  
STEARETH-21 (UNII: 53J3F32P58)  
SODIUM CHLORIDE (UNII: 451W47IQ8X)  
DOCOSANOL (UNII: 9G1OE216XY)  
STEARETH-2 (UNII: V56DFE46J5)  
XANTHAN GUM (UNII: TTV12P4NEE)  
LAURYL ALCOHOL (UNII: 178A96NLP2)  
MICA (UNII: V8A1AW0880)  
EDETATE DISODIUM ANHYDROUS (UNII: 8NLQ36F6MM)  
POLYOXYL 40 HYDROGENATED CASTOR OIL (UNII: 7YC686GQ8F)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
MAGNESIUM NITRATE (UNII: 77CBG3UN78)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
METHYLCHLOROISOTHIAZOLINONE (UNII: DEL7T5QRPN)  
MAGNESIUM CHLORIDE (UNII: 02F3473H9O)  
BUTYLPARABEN (UNII: 3QPI1U3FV8)  
ETHYLPARABEN (UNII: 14255EXE39)  
ISOBUTYLPARABEN (UNII: 0QQJ25X58G)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)  
FERRIC FERROCYANIDE (UNII: TLE294X33A)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63824-318-011 in 1 CARTON08/18/200909/01/2024
1150 mL in 1 BOTTLE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D08/18/200909/01/2024
Labeler - RB Health (US) LLC (081049410)

Revised: 7/2023
Document Id: 00de6498-6753-765a-e063-6394a90aea20
Set id: d8baf9e5-1bea-4d1e-858c-e490db895f5d
Version: 3
Effective Time: 20230719
 
RB Health (US) LLC